Sunrest Lifescience Ltd
₹ 69.9
3.94%
25 Apr
- close price
About
Incorporated in 2017, Sunrest Lifescience Limited offers a diverse range of healthcare and personal care products.[1]
Key Points
- Market Cap ₹ 30.0 Cr.
- Current Price ₹ 69.9
- High / Low ₹ 84.0 / 57.4
- Stock P/E 14.7
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 58.6 %
- ROE 97.6 %
- Face Value ₹ 10.0
Pros
- Company has a good return on equity (ROE) track record: 3 Years ROE 99.7%
Cons
- Company might be capitalizing the interest cost
- Company has high debtors of 165 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|
| 10.64 | 15.79 | 24.60 | 24.04 | |
| 10.49 | 15.51 | 23.49 | 21.14 | |
| Operating Profit | 0.15 | 0.28 | 1.11 | 2.90 |
| OPM % | 1.41% | 1.77% | 4.51% | 12.06% |
| 0.00 | 0.00 | 0.02 | 0.03 | |
| Interest | 0.00 | 0.01 | 0.02 | 0.06 |
| Depreciation | 0.02 | 0.04 | 0.06 | 0.13 |
| Profit before tax | 0.13 | 0.23 | 1.05 | 2.74 |
| Tax % | 76.92% | 21.74% | 25.71% | 25.55% |
| 0.04 | 0.17 | 0.78 | 2.04 | |
| EPS in Rs | 40.00 | 170.00 | 780.00 | 6.80 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 31% |
| TTM: | -2% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 271% |
| TTM: | 168% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 100% |
| Last Year: | 98% |
Balance Sheet
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
|---|---|---|---|---|---|
| Equity Capital | 0.01 | 0.01 | 0.01 | 3.00 | 3.00 |
| Reserves | 0.12 | 0.28 | 1.06 | 0.11 | 2.10 |
| 2.27 | 2.31 | 3.24 | 2.14 | 4.46 | |
| 3.85 | 6.88 | 8.71 | 11.47 | 9.47 | |
| Total Liabilities | 6.25 | 9.48 | 13.02 | 16.72 | 19.03 |
| 0.03 | 0.15 | 0.47 | 0.35 | 0.31 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.02 | 0.02 |
| 6.22 | 9.33 | 12.55 | 16.35 | 18.70 | |
| Total Assets | 6.25 | 9.48 | 13.02 | 16.72 | 19.03 |
Cash Flows
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|
| -0.90 | 0.15 | -0.44 | 1.15 | |
| -0.01 | -0.16 | -0.36 | -0.03 | |
| 1.11 | 0.04 | 0.90 | -1.15 | |
| Net Cash Flow | 0.20 | 0.03 | 0.11 | -0.03 |
Ratios
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|
| Debtor Days | 184.22 | 171.06 | 138.73 | 164.89 |
| Inventory Days | 23.71 | 48.88 | 48.05 | 96.71 |
| Days Payable | 174.84 | 206.14 | 165.68 | 211.59 |
| Cash Conversion Cycle | 33.08 | 13.80 | 21.10 | 50.01 |
| Working Capital Days | 69.64 | 48.08 | 49.56 | 66.81 |
| ROCE % | 9.60% | 30.39% | 58.58% |
Documents
Announcements
Annual reports
No data available.
Product Portfolio[1] Capsules, Tablets, Syrup, Ointment, Gel, mouthwash, Solution, Suspension, Dry Powders, and Toothpaste. Sunrest Lifescience's product portfolio encompasses an extensive range of drugs such as Anti-Bacterial, Anti Diarrheal, AntiFungal, Anti Malerial, Anti Diabetic, Dental Cure, Anti Protozol, Anti Histamine, Anti-Hypertensive drugs, Cosmetic, Anti Parasitic, Multivitamin, Multimineral, Nutraceutical, and Anti-inflammatory.